Renaissance Capital logo

ALMR News

Protein biomarker detection platform Alamar Biosciences prices upsized IPO at $17, the high end of the range

Alamar Biosciences logo

Alamar Biosciences, which provides a protein biomarker detection platform for disease detection research, raised $191 million by offering 11.3 million shares at $17, the high end of the $15 to $17 range. The company sold 20% more shares than the 9.4 million...read more

Protein biomarker detection platform Alamar Biosciences sets terms for $150 million IPO

Alamar Biosciences logo

Alamar Biosciences, which provides a protein biomarker detection platform for disease detection research, announced terms for its IPO on Monday. The Fremont, CA-based company plans to raise $150 million by offering 9.4 million shares at a price range of $15 to ...read more

US IPO Week Ahead: 2 billion-dollar IPOs on the calendar, as ceasefire hopes entice more issuers

MAIR

Updated Monday, 4/13. Five sizable IPOs are currently scheduled in the week ahead, and some smaller issuers may join the calendar throughout the week. Indoor air systems provider Madison Air Solutions (MAIR) is set to raise $2.2 billion at a $12.9 billion...read more

US Weekly Recap: Aerospace and healthcare issuers drive late-March filing activity

IPFXU

While there were no traditional IPOs this past week, three blank check companies priced, and several sizable deals joined the pipeline. The week’s three blank check IPOs were led by Inflection Point Acquisition VI (IPFXU), which raised $220 million to...read more